Effectiveness of Adjuvant Homoeopathy in Management of HIV
Phase 3
- Conditions
- Health Condition 1: B20- Human immunodeficiency virus [HIV]disease
- Registration Number
- CTRI/2023/12/060660
- Lead Sponsor
- Central Council for Research in Homoeopathy, Ministry of AYUSH, Government of India
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Diagnosed case of HIV infection as per National AIDS Control Programme (NACP-IV) guidelines
2. Undergoing ART
3. Written informed consent
Exclusion Criteria
Severe Co-morbidities like - Pneumocystis (jiroveci) Pneumonia, active Mycobacterium Tuberculosis, VDRL Reactive, Hepatitis B positive, Hepatitis C positive and cancers.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method CD4+ cell count and HIV viral loadTimepoint: Baseline, 6th, 12th, 18th & 24th month
- Secondary Outcome Measures
Name Time Method Biochemical & metabolic parameters – CBC, FBS, HbA1C, BT, CT, PT, PTT, D-dimer LFT, KFT & Fasting Lipid ProfileTimepoint: Baseline, 6th, 12th, 18th, 24th month;Duration of sustained viral suppression.Timepoint: Baseline, 6th, 12th, 18th, 24th month;Symptom management of HIV on SSC-HIV rev scaleTimepoint: Baseline, every 2 months till 2 years;Time to reach CD4+ cell count of 500 cells/µlTimepoint: Baseline, 6th, 12th, 18th, 24th month;Time to reach virological suppression (HIV viral load < 1000 copies/ ml)Timepoint: Baseline, 6th, 12th, 18th, 24th month;WHO-Quality of Life (WHOQOL-HIV BREF)Timepoint: Baseline, every month till 2 years
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie adjuvant homoeopathy's impact on HIV viral load and immune markers?
How does adjuvant homoeopathy compare to standard ART in improving CD4+ T-cell counts and reducing HIV-related complications?
What biomarkers are associated with response to adjuvant homoeopathy in CTRI/2023/12/060660 HIV trial?
What are the potential adverse events associated with adjuvant homoeopathy in HIV management and how are they managed?
What are the current integrative approaches combining homoeopathy with antiretroviral drugs for HIV treatment?